Correction to: Effect of TELEmedicine for Inflammatory Bowel Disease on Patient Activation and Self-Efficacy
- 81 Downloads
Correction to: Digestive Diseases and Sciences https://doi.org/10.1007/s10620-018-5433-5
This manuscript is a secondary analysis of a large multicenter randomized controlled trial. The primary study is Cross RK et al., A Randomized Controlled Trial of TELEmedicine for patients with Inflammatory Bowel Disease (TELE-IBD). Am J Gastroenterol, 2019 Mar. https://doi.org/10.1038/s41395-018-0272-8.
Fig. 1 is adapted from a similar figure in the primary study referenced above.
In Table 1, the participant sample sizes are entered incorrectly. They should be n = 187 total participants, n = 65 in the standard care arm, n = 65 in the TELE-IBD EoW arm, and n = 57 in the TELE-IBD weekly arm.
Exclusion criteria can be found in the Study Participants section of the Methods.